Interim efficacy analysis of the phase 2 dose de-escalation trial of stereotactic arrhythmia radioablation for ventricular tachycardia (StAR-VT)

30 March 2025 (08:00 - 15:30)

Organised by:

Sign in to view the resources

About the speaker

Doctor Deepti Ranganathan

McGill University Health Centre, Montreal (Canada)

146 More presentations in this session

Presentation thumbnail

Impact of ICD and CRT-D implantation on survival in ischemic and non-ischemic cardiomyopathy: a single-center croatian retrospective cohort study and comparative insights with the DANISH trial

Assistant Professor M. Puljevic (Zagreb, HR)

Presentation thumbnail

Do the longer leadless pacemakers with helix screws affect tricuspid regurgitation after pacemaker implantation?

Presentation thumbnail

Classification of atrial fibrillation burden pattern in cardiac implantable electronic devices

Mr S. Majumder (Minneapolis, US)

Abstract Slides Video

Presentation thumbnail

Life-threatening arrhythmia in patients with suspected acute myocarditis

Miss K. Bulatova (Basel, CH)

Abstract Slides Video

Presentation thumbnail

Early outcomes of left bundle branch area pacing upgrade in pediatric pacing-induced cardiomyopathy

Mr Y. Turubayev (Astana, KZ)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

The Event

Event poster

EHRA 2025

30 March - 1 April 2025

You may be interested in

Congress Presentation

Preferred approach in bailout procedures: radiation therapy

Congress Presentation

A ventricular tachycardia case not treatable with transcatheter ablation due to apical thrombosis of the left ventricle resolved with radiotherapy based on the non-invasive mapping system

Congress Session

Ventricular storm (2)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources